Klinikum der Universitaet in Muenchen ( Site 0446)

Munich, Bavaria 81377

0 studies enrolling now · 2 studies all time

What they study most

Gastric Cancer, Gastroesophageal Junction Cancer, Uterine Cervical Neoplasms

Studies at this site

• Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585) — Completed
• Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047) — Completed